Drug Shortages Slightly Rise in 2025, Llama Antibodies Gain Attention

As the work week concludes, weekend plans beckon. Our agenda remains flexible due to a potential storm, but we intend to prioritize essentials like caffeine, reading, films, and a listening party featuring tracks like this, this, this, this, and this. Perhaps you’ll cook, connect with loved ones, or organize your space. A trip to Greenland is always an option. Whatever your choice, prioritize safety and enjoyment.

Moderna CEO Stéphane Bancel announced the company will not invest in new late-stage vaccine trials due to increasing opposition to immunizations from U.S. officials, according to Bloomberg News. Bancel’s statement represents his most direct commentary yet on the challenges vaccine manufacturers face under the current administration. He joins other pharmaceutical leaders expressing frustration with the government’s stance on immunizations. Led by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a known vaccine critic, officials have restricted eligibility for Covid vaccines and created conf